The utilization of massive doses of antimicrobial agents with isolation perfusion in the treatment of chronic osteomyelitis. Intermediate term results.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D010478:Chemotherapy, Cancer, Regional Perfusion; D002701:Chloramphenicol / Q000008:administration & dosage; D002751:Chlortetracycline / Q000008:administration & dosage; D005260:Female; D005269:Femur; D006801:Humans; D006811:Humerus; D007612:Kanamycin / Q000008:administration & dosage; D008297:Male; D008684:Metatarsus; D008712:Methicillin / Q000008:administration & dosage; D008875:Middle Aged; D009355:Neomycin / Q000008:administration & dosage; D010019:Osteomyelitis / Q000188:drug therapy*; D010118:Oxytetracycline / Q000008:administration & dosage; D011479:Protamines / Q000008:administration & dosage; D013307:Streptomycin / Q000008:administration & dosage; D013752:Tetracycline / Q000008:administration & dosage; D013977:Tibia
D000900:Anti-Bacterial Agents; D011479:Protamines; D007612:Kanamycin; D002701:Chloramphenicol; D013752:Tetracycline; D009355:Neomycin; D008712:Methicillin; D002751:Chlortetracycline; D010118:Oxytetracycline; D013307:Streptomycin